Company Filing History:
Years Active: 2012
Title: Christopher D Willey: Innovator in Vascular Endothelium Research
Introduction
Christopher D Willey is a notable inventor based in Birmingham, AL (US). He has made significant contributions to the field of vascular biology, particularly in the modulation of cell proliferation and radiosensitivity.
Latest Patents
Willey holds a patent titled "Bmx mediated signal transduction in irradiated vascular endothelium." This patent provides methods for modulating the proliferation of cells and tissues. The methods include administering an effective amount of a modulator of a biological activity of a bone marrow X kinase (Bmx) gene product. Additionally, the patent outlines methods for increasing the radiosensitivity of target cells or tissues, suppressing tumor growth, inhibiting tumor blood vessel growth, and compositions that include modulators of Bmx gene product activity. He has 1 patent to his name.
Career Highlights
Willey is affiliated with Vanderbilt University, where he continues to advance research in his field. His work has implications for cancer treatment and understanding cellular responses to radiation.
Collaborations
One of his notable collaborators is Dennis E Hallahan, with whom he has worked on various research projects.
Conclusion
Christopher D Willey is a prominent figure in the realm of vascular endothelium research, with a focus on innovative methods to enhance cancer treatment. His contributions are paving the way for future advancements in medical science.